Aptorum Group is a pharmaceutical company dedicated to the development of therapeutic assets to treat diseases with unmet medical needs.
Aptorum Group has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Aptorum Group's investors include Aenco Technologies.
Aptorum Group is headquartered in London, United Kingdom.
Aptorum Group is a pharmaceutical company dedicated to the development of therapeutic assets to treat diseases with unmet medical needs.
Aptorum Group is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aptorum Group — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/aptorum-group. Accessed September 29, 2026.
VCBacked. (2025). Aptorum Group — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/aptorum-group
{{cite web |title=Aptorum Group — Funding & Investors |url=https://www.vcbacked.co/company/aptorum-group |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated